vs
Foghorn Therapeutics Inc.（FHTX）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
NexPoint Real Estate Finance, Inc.的季度营收约是Foghorn Therapeutics Inc.的1.2倍（$11.1M vs $9.2M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -234.3%，领先450.9%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs -48.8%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
FHTX vs NREF — 直观对比
营收规模更大
NREF
是对方的1.2倍
$9.2M
营收增速更快
FHTX
高出272.6%
-48.8%
净利率更高
NREF
高出450.9%
-234.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $11.1M |
| 净利润 | $-21.7M | $24.0M |
| 毛利率 | — | — |
| 营业利润率 | -258.2% | — |
| 净利率 | -234.3% | 216.6% |
| 营收同比 | 223.8% | -48.8% |
| 净利润同比 | -11.1% | 58.7% |
| 每股收益（稀释后） | $-0.35 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXNREF
| Q4 25 | $9.2M | $11.1M | ||
| Q3 25 | $8.2M | $12.5M | ||
| Q2 25 | $7.6M | $12.1M | ||
| Q1 25 | $6.0M | $11.5M | ||
| Q4 24 | $2.9M | $21.7M | ||
| Q3 24 | $7.8M | $12.5M | ||
| Q2 24 | $6.9M | $6.7M | ||
| Q1 24 | $5.0M | $-12.8M |
净利润FHTXNREF
| Q4 25 | $-21.7M | $24.0M | ||
| Q3 25 | $-15.8M | $50.9M | ||
| Q2 25 | $-17.9M | $22.3M | ||
| Q1 25 | $-18.8M | $26.0M | ||
| Q4 24 | $-19.5M | $15.2M | ||
| Q3 24 | $-19.1M | $23.3M | ||
| Q2 24 | $-23.0M | $12.1M | ||
| Q1 24 | $-25.0M | $-14.6M |
营业利润率FHTXNREF
| Q4 25 | -258.2% | — | ||
| Q3 25 | -226.9% | — | ||
| Q2 25 | -279.2% | — | ||
| Q1 25 | -385.0% | — | ||
| Q4 24 | -840.5% | — | ||
| Q3 24 | -305.5% | — | ||
| Q2 24 | -386.6% | — | ||
| Q1 24 | -558.3% | — |
净利率FHTXNREF
| Q4 25 | -234.3% | 216.6% | ||
| Q3 25 | -194.4% | 407.0% | ||
| Q2 25 | -237.3% | 184.5% | ||
| Q1 25 | -316.4% | 225.6% | ||
| Q4 24 | -682.9% | 69.9% | ||
| Q3 24 | -244.9% | 186.4% | ||
| Q2 24 | -333.6% | 179.7% | ||
| Q1 24 | -495.4% | 114.3% |
每股收益（稀释后）FHTXNREF
| Q4 25 | $-0.35 | $0.47 | ||
| Q3 25 | $-0.25 | $1.14 | ||
| Q2 25 | $-0.28 | $0.54 | ||
| Q1 25 | $-0.30 | $0.70 | ||
| Q4 24 | $-0.23 | $0.71 | ||
| Q3 24 | $-0.31 | $0.74 | ||
| Q2 24 | $-0.45 | $0.40 | ||
| Q1 24 | $-0.59 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $31.1M |
| 总债务越低越好 | — | $771.2M |
| 股东权益账面价值 | $-108.5M | $388.0M |
| 总资产 | $198.1M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资FHTXNREF
| Q4 25 | $80.9M | $31.1M | ||
| Q3 25 | $89.3M | $17.9M | ||
| Q2 25 | $72.6M | $9.1M | ||
| Q1 25 | $61.0M | $19.2M | ||
| Q4 24 | $55.5M | $3.9M | ||
| Q3 24 | $57.7M | $34.7M | ||
| Q2 24 | $138.9M | $4.3M | ||
| Q1 24 | $79.3M | $13.5M |
总债务FHTXNREF
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | — | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益FHTXNREF
| Q4 25 | $-108.5M | $388.0M | ||
| Q3 25 | $-89.7M | $375.4M | ||
| Q2 25 | $-76.7M | $348.2M | ||
| Q1 25 | $-61.7M | $343.7M | ||
| Q4 24 | $-45.5M | $336.5M | ||
| Q3 24 | $-28.3M | $335.8M | ||
| Q2 24 | $-14.3M | $327.5M | ||
| Q1 24 | $-97.5M | $327.1M |
总资产FHTXNREF
| Q4 25 | $198.1M | $5.3B | ||
| Q3 25 | $205.0M | $5.3B | ||
| Q2 25 | $226.2M | $5.4B | ||
| Q1 25 | $258.7M | $5.4B | ||
| Q4 24 | $284.0M | $5.4B | ||
| Q3 24 | $308.4M | $5.7B | ||
| Q2 24 | $328.6M | $6.6B | ||
| Q1 24 | $255.0M | $7.1B |
负债/权益比FHTXNREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FHTXNREF
| Q4 25 | $-22.3M | $-4.5M | ||
| Q3 25 | $-18.9M | $8.1M | ||
| Q2 25 | $-21.0M | $3.3M | ||
| Q1 25 | $-24.0M | $16.0M | ||
| Q4 24 | $-24.5M | $4.4M | ||
| Q3 24 | $-21.0M | $14.7M | ||
| Q2 24 | $-25.5M | $-7.5M | ||
| Q1 24 | $-29.3M | $17.7M |
自由现金流FHTXNREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | — | ||
| Q2 24 | $-25.6M | — | ||
| Q1 24 | $-29.4M | — |
自由现金流率FHTXNREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | — | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | — | ||
| Q2 24 | -371.0% | — | ||
| Q1 24 | -583.1% | — |
资本支出强度FHTXNREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 2.0% | — |
现金转化率FHTXNREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
